Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Todd Pitts

Concepts (400)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
24
2024
791
2.820
 Why?
Xenograft Model Antitumor Assays
38
2024
868
1.950
 Why?
Protein Kinase Inhibitors
19
2020
916
1.820
 Why?
Triple Negative Breast Neoplasms
7
2024
202
1.410
 Why?
Antineoplastic Agents
25
2020
2122
1.410
 Why?
Azepines
5
2024
90
1.370
 Why?
Histone Deacetylase Inhibitors
5
2024
210
1.220
 Why?
Cell Line, Tumor
38
2025
3405
1.160
 Why?
Pyrimidines
9
2020
470
1.150
 Why?
Mice, Nude
25
2024
696
1.130
 Why?
Pancreatic Neoplasms
7
2025
935
1.000
 Why?
Carcinoma, Pancreatic Ductal
3
2025
287
1.000
 Why?
Pyrazines
6
2018
90
1.000
 Why?
Cell Proliferation
22
2024
2475
0.930
 Why?
Apoptosis
22
2024
2551
0.760
 Why?
Fluorouracil
1
2022
208
0.730
 Why?
Proto-Oncogene Proteins
6
2018
647
0.630
 Why?
Benzimidazoles
6
2024
170
0.620
 Why?
Camptothecin
5
2022
115
0.620
 Why?
Aurora Kinase A
4
2020
56
0.610
 Why?
Imidazoles
4
2018
238
0.610
 Why?
Drug Resistance, Neoplasm
12
2024
800
0.570
 Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1682
0.550
 Why?
Drug Synergism
4
2014
382
0.540
 Why?
Mice
42
2025
17757
0.520
 Why?
Neoplasms
9
2022
2644
0.490
 Why?
Cell Cycle Proteins
2
2018
613
0.480
 Why?
Cell Cycle Checkpoints
3
2019
98
0.480
 Why?
Hydroxamic Acids
3
2011
89
0.470
 Why?
Wnt Signaling Pathway
5
2024
192
0.470
 Why?
Deoxycytidine
3
2024
179
0.470
 Why?
Receptor, IGF Type 1
3
2013
65
0.460
 Why?
Melanoma
5
2024
757
0.460
 Why?
Animals
47
2025
36847
0.450
 Why?
Disease Models, Animal
11
2025
4282
0.440
 Why?
Pyrazoles
5
2018
423
0.440
 Why?
Antimitotic Agents
1
2013
8
0.430
 Why?
Adrenocortical Carcinoma
3
2020
65
0.430
 Why?
Gene Expression Regulation, Neoplastic
10
2024
1396
0.430
 Why?
Mitogen-Activated Protein Kinases
3
2014
313
0.430
 Why?
Tumor Microenvironment
5
2022
672
0.430
 Why?
Tumor Suppressor Protein p53
5
2024
528
0.420
 Why?
Molecular Targeted Therapy
3
2024
411
0.420
 Why?
G2 Phase Cell Cycle Checkpoints
4
2022
44
0.400
 Why?
Signal Transduction
18
2024
5076
0.400
 Why?
Cyclin-Dependent Kinases
1
2013
132
0.390
 Why?
TOR Serine-Threonine Kinases
2
2018
412
0.390
 Why?
Boronic Acids
2
2011
37
0.390
 Why?
Quinoxalines
4
2020
66
0.370
 Why?
Dasatinib
2
2024
54
0.360
 Why?
Gene Expression Profiling
8
2024
1772
0.340
 Why?
Colonic Neoplasms
2
2013
254
0.340
 Why?
Drug Screening Assays, Antitumor
5
2020
194
0.340
 Why?
Humans
68
2025
136768
0.330
 Why?
Heterografts
3
2021
138
0.330
 Why?
Biomarkers, Tumor
6
2018
1272
0.330
 Why?
Programmed Cell Death 1 Receptor
3
2025
250
0.320
 Why?
Oxidoreductases Acting on CH-CH Group Donors
2
2020
26
0.310
 Why?
Phosphatidylinositol 3-Kinases
6
2018
366
0.300
 Why?
Adrenal Cortex Neoplasms
2
2020
63
0.290
 Why?
Ephrin-B2
2
2019
47
0.280
 Why?
Cell Cycle
7
2018
601
0.280
 Why?
Enzyme Inhibitors
5
2020
839
0.280
 Why?
Piperazines
2
2020
350
0.280
 Why?
Quinazolines
3
2015
250
0.270
 Why?
Drug Delivery Systems
1
2010
362
0.260
 Why?
Antibodies, Monoclonal, Humanized
2
2024
801
0.260
 Why?
Anilides
2
2018
73
0.250
 Why?
Mitogen-Activated Protein Kinase Kinases
3
2019
134
0.250
 Why?
Oncogene Proteins, Fusion
2
2018
214
0.250
 Why?
Female
41
2025
72796
0.250
 Why?
Protein-Lysine 6-Oxidase
1
2025
14
0.240
 Why?
Organoids
2
2024
112
0.240
 Why?
Gene Dosage
4
2015
140
0.240
 Why?
Mutation
9
2018
3946
0.230
 Why?
Nephritis, Interstitial
1
2025
14
0.230
 Why?
Immunoblotting
6
2015
306
0.230
 Why?
Gene Regulatory Networks
2
2024
304
0.230
 Why?
Cyclosporine
2
2018
268
0.230
 Why?
Collagen Type I
1
2025
133
0.230
 Why?
Pyrimidinones
2
2015
113
0.220
 Why?
Proto-Oncogene Proteins B-raf
3
2018
224
0.220
 Why?
Lymphocytes, Tumor-Infiltrating
3
2020
209
0.220
 Why?
RNA, Small Interfering
2
2024
622
0.210
 Why?
Bevacizumab
1
2024
135
0.210
 Why?
ras Proteins
4
2013
153
0.210
 Why?
Endogenous Retroviruses
1
2024
37
0.210
 Why?
Proto-Oncogene Proteins p21(ras)
6
2016
267
0.210
 Why?
Receptor, Notch1
2
2015
64
0.210
 Why?
Mucous Membrane
1
2024
125
0.210
 Why?
Pyridones
2
2015
168
0.210
 Why?
Neoplasm Transplantation
4
2018
257
0.210
 Why?
Collagen
1
2025
446
0.200
 Why?
Paclitaxel
1
2024
227
0.200
 Why?
Pyridines
2
2018
506
0.200
 Why?
Antineoplastic Agents, Immunological
3
2020
188
0.200
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
66
0.200
 Why?
HCT116 Cells
3
2018
80
0.200
 Why?
Immunotherapy
3
2022
640
0.190
 Why?
Doxorubicin
1
2024
362
0.190
 Why?
Drug Design
2
2013
167
0.190
 Why?
beta Catenin
2
2020
253
0.180
 Why?
Gene Knockdown Techniques
4
2020
327
0.180
 Why?
Momordica charantia
1
2020
15
0.170
 Why?
Benzoxazoles
1
2020
19
0.170
 Why?
DNA-Binding Proteins
2
2020
1501
0.170
 Why?
HT29 Cells
2
2018
40
0.160
 Why?
Neoplasms, Experimental
2
2019
176
0.160
 Why?
Immune System
1
2021
177
0.160
 Why?
eIF-2 Kinase
1
2019
31
0.160
 Why?
src-Family Kinases
2
2017
92
0.160
 Why?
Inhibitory Concentration 50
2
2016
90
0.150
 Why?
Receptor, EphB4
1
2019
34
0.150
 Why?
DNA Helicases
1
2020
145
0.150
 Why?
Tumor Burden
2
2018
309
0.150
 Why?
Breast Neoplasms, Male
1
2018
29
0.150
 Why?
Plant Extracts
1
2020
202
0.150
 Why?
Coenzymes
1
2018
19
0.150
 Why?
4-Aminobenzoic Acid
1
2018
7
0.150
 Why?
Thermodynamics
1
2020
401
0.140
 Why?
MAP Kinase Kinase Kinases
2
2015
73
0.140
 Why?
Septins
1
2018
43
0.140
 Why?
Neoplasm Proteins
2
2020
434
0.140
 Why?
Adrenal Cortex
1
2018
29
0.140
 Why?
Oncogene Proteins v-abl
1
2017
5
0.140
 Why?
Neoplasm Invasiveness
3
2020
507
0.140
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2018
35
0.140
 Why?
Angiogenesis Inhibitors
3
2018
226
0.130
 Why?
Kidney
1
2025
1467
0.130
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2014
86
0.130
 Why?
Ubiquitin-Activating Enzymes
1
2016
17
0.130
 Why?
Cyclopentanes
1
2016
19
0.130
 Why?
Transplantation, Heterologous
4
2022
194
0.130
 Why?
Skin Neoplasms
1
2024
852
0.130
 Why?
Tumor Cells, Cultured
4
2020
953
0.130
 Why?
Corynebacterium
1
2017
49
0.130
 Why?
Corynebacterium Infections
1
2017
41
0.130
 Why?
Tankyrases
1
2016
15
0.130
 Why?
Insulin-Like Growth Factor I
1
2018
316
0.120
 Why?
Cetuximab
1
2016
95
0.120
 Why?
Capecitabine
1
2015
45
0.120
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
121
0.120
 Why?
Amyloid Precursor Protein Secretases
2
2013
80
0.120
 Why?
Biliary Tract Neoplasms
1
2015
30
0.120
 Why?
Autophagy
1
2018
280
0.120
 Why?
Drug Discovery
1
2016
141
0.120
 Why?
Genes, ras
2
2018
97
0.120
 Why?
Cell Survival
3
2019
1116
0.120
 Why?
Adenocarcinoma
2
2020
938
0.120
 Why?
Diphenylamine
1
2014
9
0.120
 Why?
Gene Expression Regulation
1
2024
2605
0.110
 Why?
DNA Copy Number Variations
1
2015
182
0.110
 Why?
Germ-Line Mutation
2
2018
172
0.110
 Why?
Piperidines
1
2015
206
0.110
 Why?
Proto-Oncogene Proteins c-met
1
2014
75
0.110
 Why?
Middle Aged
14
2024
33228
0.110
 Why?
Benzamides
1
2014
216
0.110
 Why?
Protein Kinases
1
2015
319
0.110
 Why?
Up-Regulation
1
2016
844
0.100
 Why?
Urinary Bladder Neoplasms
1
2016
251
0.100
 Why?
Tetrahydronaphthalenes
1
2013
29
0.100
 Why?
Receptor, Insulin
1
2013
105
0.100
 Why?
Aged
11
2024
23794
0.100
 Why?
Valine
1
2013
82
0.100
 Why?
Neutrophils
4
2019
1236
0.100
 Why?
Bortezomib
2
2011
54
0.100
 Why?
Receptors, Notch
1
2013
88
0.100
 Why?
Tumor Suppressor Proteins
1
2015
327
0.100
 Why?
Mitosis
1
2013
192
0.100
 Why?
Antineoplastic Agents, Phytogenic
1
2013
190
0.090
 Why?
3' Untranslated Regions
1
2012
145
0.090
 Why?
Aldehyde Dehydrogenase
1
2012
100
0.090
 Why?
Sirolimus
1
2013
275
0.090
 Why?
Proteasome Inhibitors
1
2011
46
0.090
 Why?
Carcinoma, Squamous Cell
1
2016
683
0.090
 Why?
Head and Neck Neoplasms
1
2016
604
0.090
 Why?
Computational Biology
1
2015
643
0.090
 Why?
Benzodioxoles
1
2012
115
0.090
 Why?
Protease Inhibitors
1
2011
107
0.080
 Why?
Carcinogenesis
2
2024
217
0.080
 Why?
Proto-Oncogene Proteins c-akt
4
2018
437
0.080
 Why?
Mice, Inbred NOD
2
2022
600
0.080
 Why?
Phosphorylation
4
2019
1758
0.080
 Why?
Neoplasm Metastasis
3
2018
657
0.080
 Why?
Nuclear Proteins
1
2015
712
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
7
0.080
 Why?
Adult
12
2024
37630
0.080
 Why?
Mice, Inbred BALB C
3
2020
1269
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2009
71
0.080
 Why?
Breast Neoplasms
2
2012
2234
0.080
 Why?
Class I Phosphatidylinositol 3-Kinases
3
2014
95
0.070
 Why?
Gastrointestinal Neoplasms
1
2009
77
0.070
 Why?
Cell Movement
2
2011
968
0.070
 Why?
Male
15
2024
67311
0.070
 Why?
Positron-Emission Tomography
3
2018
293
0.070
 Why?
Immunosuppressive Agents
1
2013
889
0.070
 Why?
Carcinoma, Hepatocellular
1
2011
361
0.070
 Why?
Prognosis
4
2019
4013
0.070
 Why?
Farnesyltranstransferase
1
2007
35
0.070
 Why?
Oligonucleotide Array Sequence Analysis
3
2015
766
0.060
 Why?
Feasibility Studies
1
2010
951
0.060
 Why?
Protein Conformation
2
2020
933
0.060
 Why?
Microsatellite Repeats
2
2024
168
0.060
 Why?
Gene Expression
2
2019
1500
0.060
 Why?
Algorithms
3
2024
1689
0.060
 Why?
Transcription, Genetic
2
2024
1455
0.060
 Why?
Maximum Tolerated Dose
2
2020
199
0.060
 Why?
Reproducibility of Results
2
2010
3264
0.060
 Why?
Quinolones
1
2007
137
0.060
 Why?
Ipilimumab
1
2025
33
0.060
 Why?
Neovascularization, Pathologic
2
2018
301
0.060
 Why?
Disease Progression
2
2025
2750
0.060
 Why?
CTLA-4 Antigen
1
2025
99
0.060
 Why?
Models, Molecular
2
2020
1570
0.050
 Why?
Structure-Activity Relationship
2
2018
570
0.050
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2019
41
0.050
 Why?
Triazoles
1
2024
147
0.050
 Why?
Enhancer Elements, Genetic
1
2024
190
0.050
 Why?
HMGB1 Protein
1
2003
50
0.050
 Why?
Adrenergic alpha-Agonists
1
2002
28
0.050
 Why?
Proto-Oncogene Proteins c-raf
1
2002
45
0.050
 Why?
Adrenergic alpha-Antagonists
1
2002
34
0.050
 Why?
Neuroimmunomodulation
1
2002
65
0.050
 Why?
Magnetic Resonance Spectroscopy
2
2018
610
0.050
 Why?
Histone Deacetylase 1
1
2022
25
0.050
 Why?
Isoenzymes
1
2003
304
0.050
 Why?
Aurora Kinases
2
2012
27
0.050
 Why?
Histones
2
2022
636
0.050
 Why?
Treatment Outcome
4
2024
10744
0.050
 Why?
Adrenergic beta-Agonists
1
2002
133
0.050
 Why?
Endotoxemia
1
2002
86
0.050
 Why?
Genetic Predisposition to Disease
1
2010
2412
0.040
 Why?
Caspase 3
2
2013
246
0.040
 Why?
Chimerism
1
2021
31
0.040
 Why?
Acetylation
1
2022
248
0.040
 Why?
Extracellular Matrix
1
2025
528
0.040
 Why?
Flow Cytometry
2
2019
1180
0.040
 Why?
Campylobacter jejuni
1
2000
12
0.040
 Why?
Lymphocyte Subsets
1
2021
87
0.040
 Why?
Lymphoid Tissue
1
2021
75
0.040
 Why?
Cluster Analysis
2
2012
497
0.040
 Why?
Catalase
1
2000
130
0.040
 Why?
TCF Transcription Factors
1
2020
17
0.040
 Why?
Adrenergic beta-Antagonists
1
2002
323
0.040
 Why?
Histone Deacetylases
1
2022
215
0.040
 Why?
RNA, Neoplasm
1
2020
82
0.040
 Why?
Mice, SCID
1
2021
366
0.040
 Why?
Antimetabolites, Antineoplastic
1
2020
94
0.040
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.040
 Why?
Indolizines
1
2019
4
0.040
 Why?
Forkhead Box Protein M1
1
2019
7
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
125
0.040
 Why?
Small Molecule Libraries
1
2020
94
0.040
 Why?
MAP Kinase Kinase 2
2
2013
28
0.040
 Why?
Genomics
1
2024
790
0.040
 Why?
MAP Kinase Kinase 1
2
2013
75
0.040
 Why?
Crystallography, X-Ray
1
2020
476
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
 Why?
Genetic Linkage
1
1999
297
0.040
 Why?
High-Throughput Screening Assays
1
2020
158
0.040
 Why?
Flavin-Adenine Dinucleotide
1
2018
16
0.040
 Why?
NADP
1
2018
49
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2020
209
0.040
 Why?
Radiotherapy
1
2019
201
0.040
 Why?
Nausea
1
2018
111
0.040
 Why?
Aldosterone
1
2018
45
0.040
 Why?
Multifactorial Inheritance
1
1999
174
0.040
 Why?
Kaplan-Meier Estimate
1
2020
888
0.040
 Why?
Hemorrhage
1
2002
721
0.030
 Why?
Area Under Curve
1
2018
314
0.030
 Why?
Drug Therapy, Combination
1
2020
1062
0.030
 Why?
Breast
1
2018
149
0.030
 Why?
Catalytic Domain
1
2018
207
0.030
 Why?
DNA Damage
1
2020
420
0.030
 Why?
Diarrhea
1
2018
184
0.030
 Why?
RNA
1
2024
921
0.030
 Why?
Recombinant Proteins
1
2020
1350
0.030
 Why?
Autistic Disorder
1
1999
204
0.030
 Why?
Disease-Free Survival
1
2018
685
0.030
 Why?
Axin Protein
1
2016
19
0.030
 Why?
Ubiquitination
1
2016
102
0.030
 Why?
Fatigue
1
2018
327
0.030
 Why?
T-Lymphocytes, Regulatory
1
2019
387
0.030
 Why?
RNA, Messenger
2
2020
2831
0.030
 Why?
Protein Isoforms
1
2017
403
0.030
 Why?
Administration, Oral
1
2018
813
0.030
 Why?
Hypertension
2
2018
1284
0.030
 Why?
Sequence Analysis, RNA
1
2018
452
0.030
 Why?
Serrate-Jagged Proteins
1
2015
27
0.030
 Why?
Jagged-1 Protein
1
2015
23
0.030
 Why?
Tumor Protein p73
1
2015
14
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
614
0.030
 Why?
Gene Duplication
1
2015
68
0.030
 Why?
Binding Sites
1
2018
1301
0.030
 Why?
Biopsy
1
2018
1124
0.030
 Why?
NF-kappa B
3
2003
691
0.030
 Why?
Immunohistochemistry
1
2019
1733
0.030
 Why?
Databases, Genetic
1
2015
237
0.030
 Why?
Calcium-Binding Proteins
1
2015
218
0.030
 Why?
Mice, Knockout
1
2021
3008
0.030
 Why?
Caspase 7
1
2013
22
0.030
 Why?
Butadienes
1
2013
36
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2015
382
0.030
 Why?
Cell Growth Processes
1
2013
52
0.030
 Why?
Survival Analysis
1
2016
1321
0.030
 Why?
Tumor Stem Cell Assay
1
2012
34
0.030
 Why?
Everolimus
1
2013
91
0.020
 Why?
Nitriles
1
2013
172
0.020
 Why?
Random Allocation
1
2013
353
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2019
913
0.020
 Why?
Phenotype
1
2021
3189
0.020
 Why?
Immunoprecipitation
1
2012
155
0.020
 Why?
Cyclic AMP Response Element-Binding Protein
2
2003
145
0.020
 Why?
Neoplasm Staging
1
2015
1371
0.020
 Why?
p38 Mitogen-Activated Protein Kinases
2
2003
283
0.020
 Why?
Calcium Signaling
1
2013
249
0.020
 Why?
Kinetics
1
2014
1664
0.020
 Why?
Enzyme Activation
2
2003
810
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2012
317
0.020
 Why?
PTEN Phosphohydrolase
1
2012
162
0.020
 Why?
Cellular Senescence
1
2012
187
0.020
 Why?
Li-Fraumeni Syndrome
1
2010
14
0.020
 Why?
Receptor, ErbB-2
1
2012
340
0.020
 Why?
Molecular Epidemiology
1
2010
67
0.020
 Why?
Proteasome Endopeptidase Complex
1
2011
155
0.020
 Why?
Population Groups
1
2010
62
0.020
 Why?
Neutropenia
1
2010
146
0.020
 Why?
Ki-67 Antigen
1
2010
111
0.020
 Why?
Capillary Permeability
1
2010
145
0.020
 Why?
Metabolome
1
2013
350
0.020
 Why?
Ligands
1
2011
661
0.020
 Why?
Drug Combinations
1
2010
343
0.020
 Why?
Nuclear Magnetic Resonance, Biomolecular
1
2011
340
0.020
 Why?
Keratinocytes
1
2010
248
0.020
 Why?
Transcriptome
1
2015
969
0.020
 Why?
Australia
1
2010
313
0.020
 Why?
Membrane Proteins
1
2015
1163
0.020
 Why?
Antibodies, Monoclonal
1
2015
1430
0.020
 Why?
Biomarkers
1
2019
4144
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
975
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2007
14
0.020
 Why?
Sulfonamides
1
2011
513
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
851
0.020
 Why?
Verapamil
1
2007
41
0.020
 Why?
Calcium
1
2013
1197
0.020
 Why?
Blotting, Western
1
2009
1225
0.020
 Why?
Clone Cells
1
2007
266
0.020
 Why?
Dose-Response Relationship, Drug
1
2010
2052
0.020
 Why?
Magnetic Resonance Imaging
1
2018
3555
0.020
 Why?
Calcium Channel Blockers
1
2007
167
0.020
 Why?
Family
1
2010
665
0.020
 Why?
Metabolomics
1
2011
678
0.010
 Why?
MicroRNAs
1
2012
692
0.010
 Why?
Cohort Studies
1
2015
5701
0.010
 Why?
Liver Neoplasms
1
2011
785
0.010
 Why?
Ovarian Neoplasms
1
2010
562
0.010
 Why?
Phosphotransferases
1
2003
24
0.010
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2003
4
0.010
 Why?
bcl-Associated Death Protein
1
2003
9
0.010
 Why?
Phentolamine
1
2002
15
0.010
 Why?
Ribosomal Protein S6 Kinases
1
2002
21
0.010
 Why?
Brimonidine Tartrate
1
2002
10
0.010
 Why?
Propranolol
1
2002
50
0.010
 Why?
Phenylephrine
1
2002
75
0.010
 Why?
Mice, Mutant Strains
1
2003
298
0.010
 Why?
Adolescent
2
2018
21382
0.010
 Why?
Chemokines
1
2003
228
0.010
 Why?
Peroxidase
1
2002
175
0.010
 Why?
Mitogen-Activated Protein Kinase 3
1
2002
152
0.010
 Why?
Biological Transport
1
2003
416
0.010
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2003
233
0.010
 Why?
Cyclic AMP-Dependent Protein Kinases
1
2002
135
0.010
 Why?
Young Adult
1
2018
13129
0.010
 Why?
Respiratory Burst
1
2000
16
0.010
 Why?
omega-N-Methylarginine
1
2000
27
0.010
 Why?
MAP Kinase Signaling System
1
2002
320
0.010
 Why?
Inflammation Mediators
1
2003
513
0.010
 Why?
Protein Processing, Post-Translational
1
2002
465
0.010
 Why?
Statistical Distributions
1
1999
8
0.010
 Why?
Matched-Pair Analysis
1
1999
39
0.010
 Why?
Cloning, Molecular
1
2000
534
0.010
 Why?
Intelligence Tests
1
1999
57
0.010
 Why?
Chromosomes, Human
1
1999
44
0.010
 Why?
Nuclear Family
1
1999
54
0.010
 Why?
Lipopolysaccharides
1
2003
886
0.010
 Why?
Protein-Tyrosine Kinases
1
2002
434
0.010
 Why?
Hydrogen Peroxide
1
2000
327
0.010
 Why?
Linkage Disequilibrium
1
1999
268
0.010
 Why?
Carrier Proteins
1
2003
769
0.010
 Why?
Models, Genetic
1
1999
599
0.010
 Why?
Cells, Cultured
1
2003
4191
0.010
 Why?
Cell Line
1
2000
2838
0.010
 Why?
Cytokines
1
2003
2084
0.010
 Why?
Molecular Sequence Data
1
1999
2894
0.010
 Why?
Genotype
1
1999
1914
0.010
 Why?
Sex Factors
1
1999
2060
0.010
 Why?
Macrophages
1
2000
1544
0.010
 Why?
Mice, Inbred C57BL
1
2003
5749
0.010
 Why?
Child, Preschool
1
1999
11000
0.000
 Why?
Child
1
1999
21822
0.000
 Why?
Pitts's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (400) concept(s)
_
Co-Authors Expand Description
See all (86) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)